Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Rheumatic Diseases Clinical Trials
Rheumatic Diseases clinical trials are recruiting across 19 cities. Here are the cities with the most active studies:
Rheumatic Diseases Trial Phases
6 research organizations are sponsoring rheumatic diseases trials.
About Rheumatic Diseases
Rheumatic diseases encompass over 200 conditions affecting joints, bones, muscles, and connective tissues. They include arthritis, lupus, fibromyalgia, and many others. Treatment varies by specific condition but often involves anti-inflammatory medications, DMARDs, and biologics.
Clinical trials are advancing new treatments for rheumatic diseases. Currently, 6 studies are recruiting a combined 33,514 participants across the United States. Research is being conducted by 6 organizations including Duke University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Yale University and 3 others.
2026 Rheumatic Diseases Research Landscape
As of July 2026, the rheumatic diseases clinical trial landscape includes 6 actively recruiting studies across 19 cities in the United States. These studies are collectively seeking 33,514 participants, with an average enrollment target of 5,586 per study.
The research spans multiple phases of development: 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some rheumatic diseases treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 6 different organizations, including Duke University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Yale University, GlaxoSmithKline, Boehringer Ingelheim, and 1 others.
Geographically, rheumatic diseases trials are most concentrated in New Haven, Connecticut (3 trials); Birmingham, Alabama (2 trials); Los Angeles, California (2 trials); San Diego, California (2 trials); Phoenix, Arizona (1 trial) and 7 other cities.
Featured Rheumatic Diseases Studies
Highlighted recruiting studies for rheumatic diseases, selected by enrollment size and research scope.
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Studies of the Natural History of Rheumatic Diseases
This study will explore the causes of rheumatic diseases and why many of them affect certain minority communities more severely. Rheumatic diseases may cause joint pain, stiffness or swelling. Some can involve bones, muscles, tendons or ligaments. Some cause abnormalities of the immune system-the body s defense against disease. Some rheumatic diseases are painful or deforming and some can be life ...
Rheumatology Patient Registry and Biorepository
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Frequently Asked Questions About Rheumatic Diseases Clinical Trials
Are there rheumatic diseases clinical trials near me?
Yes, there are 6 rheumatic diseases clinical trials currently recruiting across 19+ cities in the United States, including New Haven, Connecticut; Birmingham, Alabama; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a rheumatic diseases clinical trial?
To join a rheumatic diseases clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are rheumatic diseases clinical trials free?
Yes, participation in rheumatic diseases clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of rheumatic diseases treatments are being studied?
Current rheumatic diseases clinical trials are testing a range of approaches across PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 6 research organizations.
Is it safe to participate in rheumatic diseases clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov